Demuth Tim 4
4 · PIERIS PHARMACEUTICALS, INC. · Filed Feb 24, 2022
Insider Transaction Report
Form 4
Demuth Tim
Chief Medical Officer
Transactions
- Award
Stock Option (Right to buy)
2022-02-22+100,000→ 100,000 totalExercise: $3.03Exp: 2032-02-22→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the option shares on February 22, 2023 and as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.